Characterization of a Peptide Antibody Specific to the Adenylyl Cyclase-Associated Protein of Acanthamoeba Castellanii

Overview

Journal Korean J Parasitol

Specialty Parasitology

Date 2022 Mar 6

PMID 35247949

Authors

Min-Jeong Kim

Hae-Ahm Lee

Fu-Shi Quan

Hyun-Hee Kong

Eun-Kyung Moon

Affiliations

Soon will be listed here.

Abstract

Acanthamoeba keratitis (AK) is a rare infectious disease and accurate diagnosis has remained arduous as clinical manifestations of AK were similar to keratitis of viral, bacterial, or fungal origins. In this study, we described the production of a polyclonal peptide antibody against the adenylyl cyclase-associated protein (ACAP) of A. castellanii, and evaluated its differential diagnostic potential. Enzyme-linked immunosorbent assay revealed high titers of A. castellanii-specific IgG and IgA antibodies being present in low dilutions of immunized rabbit serum. Western blot analysis revealed that the ACAP antibody specifically interacted with A. castellanii, while not interacting with human corneal epithelial (HCE) cells and other causes of keratitis such as Fusarium solani, Pseudomonas aeruginosa, and Staphylococcus aureus. Immunocytochemistry (ICC) results confirmed the specific detection of trophozoites and cysts of A. castellanii co-cultured with HCE cells. The ACAP antibody also specifically interacted with the trophozoites and cysts of 5 other Acanthamoeba species. These results indicate that the ACAP antibody of A. castellanii can specifically detect multiple AK-causing members belonging to the genus Acanthamoeba and may be useful for differentially diagnosing Acanthamoeba infections.

Citing Articles

New Frontiers in Keratitis Diagnosis and Management.

Shareef O, Shareef S, Saeed H Biology (Basel). 2023; 12(12).

PMID: 38132315 PMC: 10740828. DOI: 10.3390/biology12121489.

Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the Keratitis in an Animal Model.

Kim M, Jo H, Sohn H, Shin H, Quan F, Kong H Pathogens. 2023; 12(4).

PMID: 37111412 PMC: 10145577. DOI: 10.3390/pathogens12040526.

Detection of from Keratitis Mouse Model Using -Specific Antibodies.

Kim M, Ham A, Park A, Sohn H, Shin H, Quan F Microorganisms. 2022; 10(9).

PMID: 36144313 PMC: 9500705. DOI: 10.3390/microorganisms10091711.

References

Clarke D, Niederkorn J . The pathophysiology of Acanthamoeba keratitis. Trends Parasitol. 2006; 22(4):175-80. DOI: 10.1016/j.pt.2006.02.004. View

Alizadeh H, Apte S, Li L, Hurt M, Howard K, Cavanagh H . Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea. 2001; 20(6):622-7. DOI: 10.1097/00003226-200108000-00013. View

Park S, Lee H, Chu K, Quan F, Kim S, Moon E . Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. PLoS One. 2020; 15(9):e0239867. PMC: 7526901. DOI: 10.1371/journal.pone.0239867. View

Walochnik J, Obwaller A, Haller-Schober E, Aspock H . Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity. Parasitol Res. 2001; 87(8):651-6. DOI: 10.1007/s004360100412. View

Field J, Nikawa J, Broek D, Macdonald B, Rodgers L, Wilson I . Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol. 1988; 8(5):2159-65. PMC: 363397. DOI: 10.1128/mcb.8.5.2159-2165.1988. View

Li L, Fu L, Wang H, Wang Y . CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer. Pathol Oncol Res. 2018; 26(1):273-279. DOI: 10.1007/s12253-018-0450-4. View

Fanselow N, Sirajuddin N, Yin X, Huang A, Stuart P . Keratitis, Pathology, Diagnosis and Treatment. Pathogens. 2021; 10(3). PMC: 7998329. DOI: 10.3390/pathogens10030323. View

Szentmary N, Daas L, Shi L, Laurik K, Lepper S, Milioti G . Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment. J Curr Ophthalmol. 2019; 31(1):16-23. PMC: 6407156. DOI: 10.1016/j.joco.2018.09.008. View

Fu J, Li M, Wu D, Liu L, Chen S, Yun J . Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma. Transl Oncol. 2015; 8(5):400-406. PMC: 4631095. DOI: 10.1016/j.tranon.2015.08.003. View

10.

Maycock N, Jayaswal R . Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes. Cornea. 2016; 35(5):713-20. DOI: 10.1097/ICO.0000000000000804. View

11.

Turner M, Cockerell E, Brereton H, Badenoch P, Tea M, Coster D . Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Int J Parasitol. 2005; 35(9):981-90. DOI: 10.1016/j.ijpara.2005.03.015. View

12.

Raghavan A, Baidwal S, Venkatapathy N, Rammohan R . The Acanthamoeba-Fungal Keratitis Study. Am J Ophthalmol. 2019; 201:31-36. DOI: 10.1016/j.ajo.2019.01.024. View

13.

Noegel A, Rivero F, Albrecht R, Janssen K, Kohler J, Parent C . Assessing the role of the ASP56/CAP homologue of Dictyostelium discoideum and the requirements for subcellular localization. J Cell Sci. 1999; 112 ( Pt 19):3195-203. DOI: 10.1242/jcs.112.19.3195. View

14.

Zhang H, Ghai P, Wu H, Wang C, Field J, Zhou G . Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem. 2013; 288(29):20966-20977. PMC: 3774366. DOI: 10.1074/jbc.M113.484535. View

15.

Sharma S, Garg P, Rao G . Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol. 2000; 84(10):1103-8. PMC: 1723254. DOI: 10.1136/bjo.84.10.1103. View

16.

Kakurina G, Kolegova E, Kondakova I . Adenylyl Cyclase-Associated Protein 1: Structure, Regulation, and Participation in Cellular Processes. Biochemistry (Mosc). 2018; 83(1):45-53. DOI: 10.1134/S0006297918010066. View

17.

Hubberstey A, Mottillo E . Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization. FASEB J. 2002; 16(6):487-99. DOI: 10.1096/fj.01-0659rev. View

18.

Lee H, Chu K, Kim M, Quan F, Kong H, Moon E . Chorismate mutase peptide antibody enables specific detection of Acanthamoeba. PLoS One. 2021; 16(4):e0250342. PMC: 8064552. DOI: 10.1371/journal.pone.0250342. View

19.

Page M, Mathers W . Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol. 2013; 2013:670242. PMC: 3694549. DOI: 10.1155/2013/670242. View

20.

Moon E, Choi H, Park S, Kong H, Quan F . Comparison of Proteins Secreted into Extracellular Space of Pathogenic and Non-pathogenic Acanthamoeba castellanii. Korean J Parasitol. 2019; 56(6):553-558. PMC: 6327195. DOI: 10.3347/kjp.2018.56.6.553. View